Metabolon, Inc. logo — Providing actionable biological insights to answer the tough...

Metabolon, Inc.

Providing actionable biological insights to answer the toughest questions in life sciences research and drug development

Founded 2000 United States Morrisville, United States 198 employees Grant Total: $246.60M Biotechnology, Health Care +1

General Information

Company Name Metabolon, Inc.
Founded Year 2000
Location United States Morrisville, United States
Founders / Decision Makers
Team member
Employees 198
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Metabolon, Inc.. To contact Metabolon, Inc., visit metabolon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Metabolon, Inc. compare?

A PDF of Metabolon, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Metabolon, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Metabolon, Inc.

Metabolon, Inc. is a biotechnology company headquartered in the United States. Since its establishment in 2000, the company has excelled in providing actionable biological insights for life sciences research and drug development. Leveraging its proprietary Precision Metabolomics™ platform, Metabolon has amassed the world’s largest library of compounds, comprising over 5,200 known molecules. The company's expertise extends to academia, population health, consumer products, and nutrition industries. Through its unrivaled capability to delve into the metabolome, Metabolon offers a comprehensive view of the physiological state of living beings at a specific moment, aiding in the identification of changes brought about by disease, medical intervention, diet, or the environment. Notably, the company has undertaken over 10,000 independent and collaborative studies, resulting in 2,000+ publications in leading peer-reviewed journals. Its impactful work has attracted the attention of the National Institutes of Health, which made a grant investment on 25 June 2024. For more information about Metabolon's technology, products, and services, interested parties can visit www.metabolon.com.

Business keywords: metabolomics, biological insights, drug development, precision metabolomics, biological research, clinical trials, biomarker discovery, metabolite analysis, research technologies, biotech industry, innovation, North Carolina, scientific publications, healthcare solutions

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
National Institutes of Health
25 Jun 2024
Debt Financing $60.00M 1
Trinity Capital
16 May 2024
Venture Round $25.00M -
24 Jan 2023
Debt Financing Undisclosed 2
Perceptive Advisors, Essex Woodlands Healthcare Partners
23 Sep 2020
Venture Round $72.00M 2
Perceptive Advisors, Essex Woodlands Healthcare Partners
28 Aug 2020
Venture Round $7.30M -
30 Aug 2018
Venture Round $30.00M 1
Essex Woodlands Healthcare Partners
11 Aug 2016
Venture Round $5.05M -
09 Mar 2015
Series E $15.00M 7
Camden Partners, Syngenta Ventures +5
06 Jan 2014
Series C $6.00M 6
Syngenta Ventures, 180 Degrees Capital +4
07 Dec 2009

View All 15 Funding Rounds

Metabolon, Inc. Alternatives & Competitors

View All Alternatives
Metabolon, Inc. vs
Denovo Biopharma
Denovo Biopharma United States

A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a priva...

Grant
29 employees
Biopharma, Biotechnology
Metabolon, Inc. vs
Tute Genomics
Tute Genomics United States

Tute Genomics is a Utah-based company that is powering the world's genomic knowledge with a cloud-ba...

Series A
3 employees
Biotechnology, Health Care
Metabolon, Inc. vs

Innovative biomarker solutions for improved diagnostics, enhancing patient outcomes and optimizing h...

Series B
28 employees
Biotechnology, Health Care

FAQ About Metabolon, Inc.

Providing actionable biological insights to answer the toughest questions in life sciences research and drug development
Metabolon, Inc. was founded in 2000.
Metabolon, Inc. is headquartered in Morrisville, United States.
Metabolon, Inc. operates in Biotechnology, Health Care and Life Sciences. Its work centres on metabolomics, biological insights, drug development and precision metabolomics.
Metabolon, Inc. has approximately 198 employees.
Metabolon, Inc. has completed 15 funding rounds, raising a total of $246.60M. The latest funding stage is Grant.
Top alternatives and competitors to Metabolon, Inc. include Denovo Biopharma, Tute Genomics, FIRALIS S.A., Metanomics Health, Vascular Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Metabolon, Inc. and Denovo Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Metabolon, Inc., https://bouncewatch.com/company/metabolon-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes